Tramway Ventures
tramwayventures.com
Biotechnology
As featured in
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
From a Chance Conversation at MedTech World Europe 2025 to a Signed Investment Term Sheet
Networking is at the heart of every MedTech World event. While the conference programme brings together global leaders, investors, startups, and healthcare innovators, many of the most valuable connections are made between sessions, over coffee, during ne
Read more
Report
Circular Genomics Unveils Its CircPATH Platform Following Landmark Nature Medicine Study Demonstrating Breakthrough Performance in Early Detection of Alzheimer's Disease
SAN DIEGO, July 2, 2026 /PRNewswire/ - Circular Genomics today announced the launch of CircPATH, the company's proprietary circular RNA discovery and validation engine, following the publication of landmark findings in Nature Medicine demonstrating that b
Read more
Report
Global Alzheimer's Platform Foundation Announces Strategic Collaboration and Partnership with Circular Genomics for the Transformative Bio-Hermes-001 Study
Washington D.C., May 28, 2026 - The Global Alzheimer's Platform Foundation (GAP) is pleased to announce a collaboration with the Circular Genomics, a biotechnology company revolutionizing neurological and psychiatric precision medicine, access to analyze
Read more
Report
Tramway Ventures awarded Early-Stage VC Firm of the Year by MedTech World North America 2026
Tue, 12 May 2026 More than 5,000 public votes, combined with the insights of an independent steering committee, helped determine the winners of the awards presented during Day 0 of MedTech World North America 2026 on May 11. Powered by Blue Goat Cyber, th
Read more
Report
Circular Genomics and Vitazi.ai Forge Strategic Alliance to Develop First-in-Class Multimodal Workflow for Early Alzheimer's Detection
SAN DIEGO, April 29, 2026 /PRNewswire/ - Circular Genomics, the precision neurology leader pioneering circular RNA (circRNA)-based molecular diagnostics, today announced a strategic alliance with Vitazi.ai, an innovator in AI-powered retinal imaging and o
Read more
Report
Circular Genomics Strengthens Scientific Advisory Board with the Addition of Esteemed Alzheimer's Experts
Michael Weiner, MD and Timothy Hohman, PhD, bring decades of experience in neurological diseases with a focus on Alzheimer's disease SAN DIEGO, Dec. 8, 2025 /PRNewswire/ - Circular Genomics, a leader in circular RNA (circRNA) biomarkers for precision neur
Read more
Report
Circular Genomics Announces Closure of $15 Million Series A Financing to Advance First-in-Class Circular RNA Platform for Early Detection of Alzheimer's Disease
SAN DIEGO, Dec.1, 2025 /PRNewswire/ - Circular Genomics, Inc., the world-leading developer of circular RNA-based precision medicine tools for neurology and psychiatry, today announced the successful closure of a $15 million Series A financing round. The f
Read more
Report
Circular Genomics to Unveil New Data Highlighting Circular RNAs as a Transformative New Class of Blood-Based Biomarkers for Alzheimer's Disease at CTAD 2025
New clinical data highlights circular RNAs (circRNAs) as a novel, non-invasive blood biomarker platform for the early detection of Alzheimer's Disease (AD). The research demonstrates that circRNAs offer comprehensive insights into the multiple disrupted d
Read more
Report
BennuBio acquired by California firm
The Albuquerque company, founded in 2018, will maintain a presence in the city Albuquerque Journal 12 Oct 2025 BY NATALIE ROBBINS JOURNAL STAFF WRITER Natalie Robbins covers the economy and health care for the Journal. You can reach her at nrobbins@abqjou
Read more
Report
Precision Cell Systems Acquires BennuBio to Enter the 3D Cell Culture Market
LIVERMORE, Calif., Oct. 1, 2025 /PRNewswire/ - Precision Cell Systems (PCS) today announced the acquisition of BennuBio, marking a significant entry into the rapidly growing 3D cell culture market. According to Grand View Research, the global market was v
Read more
Report
Show more news